Sudarshan Pharma Corporate Filings & Announcements

Latest corporate announcements and filings from Sudarshan Pharma on BSE

Search Inside the pdf :

Sudarshan Pharma Industries Ltd.

30 Sep 2026

37.10

-0.38%

SAST

Sudarshan Pharma Industries Ltd - 543828 - Closure of Trading Window

BSE India

The Trading Window of the Company shall remain closed with effect from October 1,2026 until the expiry of 48 hours after the declaration of financial results for the quarter and half year ended 30/Sept/2026.

pdf

Sudarshan Pharma Industries Ltd.

28 Sep 2026

37.10

-0.38%

Company Update

Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Diversification / Disinvestment

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in conitinuation of the Company''s letter dated 13/Aug/2026 regarding stake sale of 51% of the paid up capital of Ishwari Healthcare Private Limited, unlisted subsidiary of the Company, this is to inform you that the Company has completed sale of 209,100 equity shares of Rs.10/- each held by the Company. Consequent to the aforesaid sale, Ishwari Healthcare Private Limited ahs ceased to be a subsidiary of the Company.

pdf

Sudarshan Pharma Industries Ltd.

28 Sep 2026

37.10

-0.38%

Company Update

Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Diversification / Disinvestment

BSE India

pdf

Sudarshan Pharma Industries Ltd.

22 Sep 2026

37.10

-0.38%

AGM

Sudarshan Pharma Industries Ltd - 543828 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

Please find enclosed the Scrutinizer''s Report on the business transacted at the 18th Annual General Meeting of the company held on Tuesday 22/SEPT/2026 through video conferencing / other audio-visual means.

pdf

Sudarshan Pharma Industries Ltd.

22 Sep 2026

37.10

-0.38%

AGM

Sudarshan Pharma Industries Ltd - 543828 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

Please find enclosed the voting results on the business transacted at the 18th Annual General Meeting of the company held on Tuesday 22/SEPT/2026 at 3:00 p.m. through Video Conferencing/ Other Audio Visual Means.

pdf

Sudarshan Pharma Industries Ltd.

22 Sep 2026

37.10

-0.38%

AGM

Sudarshan Pharma Industries Ltd - 543828 - Proceedings Of Annual General Meeting Held On 22/SEPT/2026

BSE India

Pursuant to Regulation 30 of SEBI ( Listing Obligations and Disclosure Requirements ) Regulations, 2015 we enclose herewith the summary of proceedings of the AGM.

pdf

Sudarshan Pharma Industries Ltd.

15 Sep 2026

37.10

-0.38%

Company Update

Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

BSE India

Pursuant to Reg 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation of the Company letter no. SPIL/CS/2026-2027/57 dated 5th September 2026, this is to inform you that the proposal to acquire 9.50% equity shares of common stock of Med Therapy Biotechnology INC., USA is under due diligence as well as confirmation from Med Therapy Board of Directors decision and Board of Directors Resolution is also pending. Hence, proposal was intimated only and the Company will come back with updates at the earliest possible time.

pdf

Sudarshan Pharma Industries Ltd.

09 Sep 2026

37.10

-0.38%

SAST

Sudarshan Pharma Industries Ltd - 543828 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI …

BSE India

The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 09, 2026 for Hemal V Mehta HUF, Mrs. Devangi Hemal Mehta, Sachin V Mehta HUF and Mrs. Namrata Sachin Mehta

pdf

Sudarshan Pharma Industries Ltd.

09 Sep 2026

37.10

-0.38%

SAST

Sudarshan Pharma Industries Ltd - 543828 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI …

BSE India

The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 09, 2026 for Hemal Vasantrai Mehta

pdf

Sudarshan Pharma Industries Ltd.

05 Sep 2026

37.10

-0.38%

Company Update

Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Acquisition

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directros have at their Meeting held today, 05/Sept/2026, inter alia, approved to acquire 24,23,675.64 equity shares of the common stock, of MedTherapy Biotechnology Inc, USA, incorporated under the laws of the State of Delaware, equivalent to 9.50% of the issued and outstanding share capital of the Company. Mr. Hemal Mehta and Mr. Sachin Mehta, Promoters of the Company shall acquire 3,82,685.63 equity shares each of common stock, equivalent to 1.50% each of the issued and outstanding equity share capital of the Company. Additional details in the letter attached herewith.

pdf